EGAPP logo

EGAPP logo

Evaluation of Genomic Applications in Practice and Prevention

helixEvaluation of Genomic Applications in Practice and Prevention (EGAPP) is an initiative launched in 2004 to support a coordinated, systematic process for evaluating genetic tests and other genomic applications that are in transition from research to clinical and public health practice in the United States.

The EGAPP Working Group was established in 2005 to support the development of a systematic process for assessing the available evidence regarding the validity and utility of rapidly emerging genetic tests for clinical practice.  This independent, multidisciplinary panel prioritizes and selects tests, reviews CDC-commissioned evidence reports and other contextual factors, highlights critical knowledge gaps, and provides guidance on appropriate use of genetic tests in specific clinical scenarios.
 
What's New
announcement

EGAPP Initiative announces the next Working Group Meeting
The Working Group will hold their next meeting on May 19-20, 2008 in Atlanta.
> Read more

   
announcement

EGAPP Working Group Releases First Recommendation Statement on Genetic Testing. The recommendation statement appears in the December issue of Genetics in Medicine.

 

Recommendations
binders
Evidence Reports
clipboard
Meetings

Working Group Meeting, May 19-20, 2008
Hilton Garden Inn Atlanta Airport / Millenium Center ~ Atlanta, GA
Announcement | Agenda